Urticaria epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Urticaria}}
{{Urticaria}}
{{CMG}}
{{CMG}} {{AE}}{{Anahita}}


==Overview==
==Overview==
Line 13: Line 13:
*[[urticaria|Cholinergic urticaria]] has a 11.2% [[prevalence]] in the age group of 16–35 years.
*[[urticaria|Cholinergic urticaria]] has a 11.2% [[prevalence]] in the age group of 16–35 years.
*[[urticaria|Physical urticarias]] [[prevelance]] has been estimated 44.6% in normal subjects.<ref name="pmid8781671">{{cite journal| author=Henz BM, Jeep S, Ziegert FS, Niemann J, Kunkel G| title=Dermal and bronchial hyperreactivity in urticarial dermographism and urticaria factitia. | journal=Allergy | year= 1996 | volume= 51 | issue= 3 | pages= 171-5 | pmid=8781671 | doi=10.1111/j.1398-9995.1996.tb04582.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8781671  }} </ref><ref name="pmid14616095">{{cite journal| author=Zuberbier T| title=Urticaria. | journal=Allergy | year= 2003 | volume= 58 | issue= 12 | pages= 1224-34 | pmid=14616095 | doi=10.1046/j.1398-9995.2003.00327.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14616095  }} </ref>
*[[urticaria|Physical urticarias]] [[prevelance]] has been estimated 44.6% in normal subjects.<ref name="pmid8781671">{{cite journal| author=Henz BM, Jeep S, Ziegert FS, Niemann J, Kunkel G| title=Dermal and bronchial hyperreactivity in urticarial dermographism and urticaria factitia. | journal=Allergy | year= 1996 | volume= 51 | issue= 3 | pages= 171-5 | pmid=8781671 | doi=10.1111/j.1398-9995.1996.tb04582.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8781671  }} </ref><ref name="pmid14616095">{{cite journal| author=Zuberbier T| title=Urticaria. | journal=Allergy | year= 2003 | volume= 58 | issue= 12 | pages= 1224-34 | pmid=14616095 | doi=10.1046/j.1398-9995.2003.00327.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14616095  }} </ref>
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Age===
===Age===
Line 24: Line 20:


===Race===
===Race===
*There is no racial predilection to [disease name].
*There is no racial predilection to [[urticaria]].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].


===Gender===
===Gender===
Line 32: Line 27:
*Interestingly [[urticaria|delayed pressure urticaria]] involves [[males]] more than [[females]]. [[male]] to [[female]] ratio is 2 to 1.<ref name="pmid14616095">{{cite journal| author=Zuberbier T| title=Urticaria. | journal=Allergy | year= 2003 | volume= 58 | issue= 12 | pages= 1224-34 | pmid=14616095 | doi=10.1046/j.1398-9995.2003.00327.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14616095  }} </ref>
*Interestingly [[urticaria|delayed pressure urticaria]] involves [[males]] more than [[females]]. [[male]] to [[female]] ratio is 2 to 1.<ref name="pmid14616095">{{cite journal| author=Zuberbier T| title=Urticaria. | journal=Allergy | year= 2003 | volume= 58 | issue= 12 | pages= 1224-34 | pmid=14616095 | doi=10.1046/j.1398-9995.2003.00327.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14616095  }} </ref>


===Region===
*The majority of [disease name] cases are reported in [geographical region].
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
===Developed Countries===
===Developing Countries===


==References==
==References==
Line 59: Line 46:
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Needs overview]]

Revision as of 20:35, 20 January 2021

Urticaria Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Urticaria from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Urticaria epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Urticaria epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Urticaria epidemiology and demographics

CDC on Urticaria epidemiology and demographics

Urticaria epidemiology and demographics in the news

Blogs on Urticaria epidemiology and demographics

Directions to Hospitals Treating Urticaria

Risk calculators and risk factors for Urticaria epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]

Overview

Epidemiology and Demographics

Incidence

  • In a prospective study in a rural area the incidence of urticaria has been approximately 0.154% in one year.[1]

Prevalence

Age

Race

  • There is no racial predilection to urticaria.

Gender


References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Zuberbier T (2003). "Urticaria". Allergy. 58 (12): 1224–34. doi:10.1046/j.1398-9995.2003.00327.x. PMID 14616095.
  2. Champion RH, Roberts SO, Carpenter RG, Roger JH (1969). "Urticaria and angio-oedema. A review of 554 patients". Br J Dermatol. 81 (8): 588–97. doi:10.1111/j.1365-2133.1969.tb16041.x. PMID 5801331.
  3. Henz BM, Jeep S, Ziegert FS, Niemann J, Kunkel G (1996). "Dermal and bronchial hyperreactivity in urticarial dermographism and urticaria factitia". Allergy. 51 (3): 171–5. doi:10.1111/j.1398-9995.1996.tb04582.x. PMID 8781671.
  4. 4.0 4.1 Losol P, Yoo HS, Park HS (2014). "Molecular genetic mechanisms of chronic urticaria". Allergy Asthma Immunol Res. 6 (1): 13–21. doi:10.4168/aair.2014.6.1.13. PMC 3881394. PMID 24404388.
  5. Humphreys F, Hunter JA (1998). "The characteristics of urticaria in 390 patients". Br J Dermatol. 138 (4): 635–8. doi:10.1046/j.1365-2133.1998.02175.x. PMID 9640369.
  6. Chuamanochan M, Kulthanan K, Tuchinda P, Chularojanamontri L, Nuchkull P (2016). "Clinical features of chronic urticaria in aging population". Asian Pac J Allergy Immunol. 34 (3): 201–205. doi:10.12932/AP0708. PMID 27001657.
  7. Greaves M (2000). "Chronic urticaria". J Allergy Clin Immunol. 105 (4): 664–72. doi:10.1067/mai.2000.105706. PMID 10756214.

Template:WH Template:WS

References

Template:WH Template:WS